Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02747576 : Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma
PhaseN/A
AgesMin: 12 Years Max: 30 Years
Eligibility
Inclusion Criteria - Medulloblastoma Survivors:

- Enrolled on the SJLIFE protocol at St. Jude Children's Research Hospital (SJCRH).

- Completed treatment for medulloblastoma at SJCRH.

- Infratentorial tumor location.

- Treated with craniospinal irradiation.

- ? 5 years post diagnosis.

- Between 12 and 30 years of age at time of enrollment.

- English speaking.

Inclusion Criteria - Controls:

- Enrolled on the SJLIFE protocol as a community control.

- Between 12 and 30 years of age at time of enrollment.

- English speaking.

Exclusion Criteria - Medulloblastoma Survivors:

- Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated
with neurocognitive or social impairment (e.g., down syndrome, autism).

- History of head injury associated with neurocognitive impairment.

- Diagnosis of a serious psychiatric condition associated with neurocognitive or social
morbidities (e.g. schizophrenia).

- Currently pregnant (due to MRI studies).

- Implanted metal unsafe for MRI or medical device (i.e. pacemaker)

- Requires sedation to complete MRI.

- Legally blind or unaidable hearing loss.

- Treated for medulloblastoma <3 years of age

- Received re-irradiation to the brain.

- Completed SJLIFE HPP-19 (pilot study) at SJCRH.

Exclusion Criteria - Controls:

- No history of childhood cancer or cancer related therapy.

- First degree relative or direct friend of medulloblastoma participant.

- Diagnosis of a genetic disorder/neurodevelopmental condition associated with
neurocognitive or social impairment (e.g., down syndrome, autism).

- History of head injury associated with neurocognitive impairment.

- Diagnosis of a serious psychiatric condition associated with neurocognitive or social
morbidities (e.g. schizophrenia).

- Currently pregnant (due to MRI studies).

- Implanted metal unsafe for MRI or medical device (i.e. pacemaker).

- Requires sedation to complete MRI.

- Legally blind or unaidable hearing loss.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02747576      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740